EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sivelestat improves acute lung injury by inhibiting PI3K/AKT/mTOR signaling pathway

Yaqing Zhou, Haiyan Wang, Aiming Liu, Zunguo Pu, Qiuxia Ji, Jianhua Xu, Yuehua Xu, Ying Wang iD

PLOS ONE · 27.06.2024 · 19 (6) · e0302721

DOI: 10.1371/journal.pone.0302721 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 27.06.2024. Verfasst von Yaqing Zhou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, Hai'an People's Hospital, Hai'an County, Nantong City, Jiangsu Province, China. Hauptthemen laut MEDLINE: TOR Serine-Threonine Kinases, Acute Lung Injury, Signal Transduction, Proto-Oncogene Proteins c-akt. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fund of Science and Technology Bureau of Nantong City, Jiangsu Province, Fund of Research topic of Nantong City Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To investigate the therapeutic effect and mechanism of sivelestat sodium on acute lung injury (AIL).

Methods

A rat model for ALI/acute respiratory distress syndrome (ALI/ARDS) was established. Pathological examination of lung tissue was conducted to assess lung injury. Blood gas in the arteries was measured using a blood analyzer. Changes in PaO 2 , PaO 2 /FiO 2 , and lung wet/dry (W/D) weight ratio were carefully compared. ELISA assay was conducted to estimate cell adhesion and inflammation response. Finally, real-time reverse transcription polymerase chain reaction and western blotting assay was used to determine the activation of PI3K/AKT/mTOR pathway.

Results

ARDS in vivo model was successfully constructed by LPS injection. Compared with the sham group, PaO 2 and PaO 2 /FiO 2 were significantly lower in the vehicle group, while the lung W/D ratio, the lung injury score, NE, VCAM-1, IL-8 andTNF-αwere significantly increased. After treatment with different doses of sivelestat sodium, we found PaO 2 , PaO 2 /FiO 2 were prominently increased, while the lung W/D ratio, the lung injury score, NE, VCAM-1, IL-8, TNF-α levels were decreased in the dose-dependent manner. Meanwhile, compared with the vehicle group, the expression levels of Bax, PI3K, Akt and mTOR were significantly lower, and the expression of Bcl-2 was significantly higher after injection with sivelestat sodium.

Conclusion

Sivelestat sodium has an interventional effect on ALI in sepsis by inhibiting the PI3K/AKT/mTOR signalling pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TOR Serine-Threonine KinasesAcute Lung InjurySignal TransductionProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesGlycineSulfonamidesRats, Sprague-DawleyAnimalsRatsMaleLungDisease Models, Animal

Substanzen

TOR Serine-Threonine KinasesProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasessivelestatGlycineSulfonamidesmTOR protein, rat

Autor:innen und Institutionen

  • Department of Critical Care Medicine, Hai'an People's Hospital, Hai'an County, Nantong City, Jiangsu Province, China.
  • Department of Critical Care Medicine, Hai'an Hospital of Traditional Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nantong, Jiangsu Province, China.
  • Department of Clinical Pharmacy, Hai'an People's Hospital, Hai'an County, Nantong City, Jiangsu Province, China.
  • Department of Critical Care Medicine, Nantong First People's Hospital, Nantong City, Jiangsu Province, China.

ORCID-Profile: Ying Wang

Förderung

  • Fund of Science and Technology Bureau of Nantong City, Jiangsu Province
  • Fund of Research topic of Nantong City Health Commission

Zitieren

APA

Zhou, Y., Wang, H., Liu, A., Pu, Z., Ji, Q., Xu, J., Xu, Y., & Wang, Y. (2024). Sivelestat improves acute lung injury by inhibiting PI3K/AKT/mTOR signaling pathway. PLOS ONE, 19(6), e0302721. https://doi.org/10.1371/journal.pone.0302721

Vancouver

Zhou Y, Wang H, Liu A, Pu Z, Ji Q, Xu J, et al. Sivelestat improves acute lung injury by inhibiting PI3K/AKT/mTOR signaling pathway. PLOS ONE. 2024;19(6):e0302721. doi:10.1371/journal.pone.0302721

BibTeX
@article{Zhou2024,
  author = {Zhou, Yaqing and Wang, Haiyan and Liu, Aiming and Pu, Zunguo and Ji, Qiuxia and Xu, Jianhua and Xu, Yuehua and Wang, Ying},
  title = {Sivelestat improves acute lung injury by inhibiting PI3K/AKT/mTOR signaling pathway},
  journal = {PLOS ONE},
  year = {2024},
  volume = {19},
  number = {6},
  pages = {e0302721},
  doi = {10.1371/journal.pone.0302721}
}
Kostenlos starten →